Application of New in Situ Hybridization Probes for Ku70 and Ku80 in Tissue Microarrays of Paraffin-Embedded Malignant Melanomas: Correlation with Immunohistochemical Analysis

Human Pathology

Volumn 35, Issue 2, 2004, Pages 210-216

  Korabiowska, Monika ^a   Bauer, Hanne ^b   Quentin, Tomas ^b   Stachura, Jerzy ^b   Cordon Cardo, Carlos ^b   Brinck, Ulrich ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b NONE

Author keywords

Ku70; Ku80, in situ hybridization; Melanoma; Tissue array

Indexed keywords

DNA DEPENDENT PROTEIN KINASE; DOUBLE STRANDED DNA; KU ANTIGEN; KU89 PROTEIN; PARAFFIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CORRELATION ANALYSIS; DNA MICROARRAY; DNA REPAIR; DNA STRAND BREAKAGE; ENZYME SUBUNIT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOLECULAR PROBE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE FIXATION; TISSUE MICROARRAY;

EID: 1242319441     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2003.08.014     Document Type: Article

References (26)

1. Gao Y, Chadhuri J, Zhu C, et al: A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for Ku in V(D)J recombination. Immunity 9:367-376, 1998
2. Jeggo PA: Identification of genes involved in repair of DNA double-strand breaks in mammalian cells. Radiat Res 150:S80-S91, 1998
3. Muller C, Rodrigo G, Calsou P, et al: DNA-dependent protein kinase: A major protein involved in the cellular response to ionizing radiation. Bull Cancer 86:977-983, 1999
4. Li GC, Ouyang H, Li X, et al: Ku70: A candidate tumor suppressor gene for murine T cell lymphoma. Mol Cell 2:1-8, 1998
5. Lee ST, Moore JK, Holmes A, et al: Saccharomyces Ku70, mre11/rad50, and RPA proteins regulate adaptation to G2/M arrest after DNA damage. Cell 94:399-409, 1998
6. Korabiowska M, Tscherny M, Stachura J, et al: Differential expression of DNA nonhomologous end-joining proteins Ku70 and Ku80 in melanoma progression. Mod Pathol 15:426-433, 2002
7. Hoos A, Urist MJ, Stojadinovic A, et al: Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 158:1245-1251, 2001
8. Kononen J, Bubendorf L, Kallioniemi A, et al: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844-847, 1998
9. Kwok S, Higuchi R: Avoiding false positivities with PCR. Nature 339:237-238, 1989
10. Breitschopf H, Suchanek G, Gould RM, et al: In situ hybridization with digoxigenin labeled probes: Sensitive and reliable method applied to mvelinating rat brain. Acta Neuropathol Berl 84:581-587, 1992
11. Korabiowska M, Tscherny M, Grohmann U, et al: Decreased expression of Ku70/Ku80 proteins in malignant melanomas of the oral cavity. Anticancer Res 22:193-196, 2002
12. Komuro Y, Watanabe T, Hosoi Y, et al: The expression pattern of Ku correlates with tumor radiosensitivity and disease-free survival in patients with rectal carcinoma. Cancer 95:1199-1205, 2002
13. Hoon ChN, Cordon-Cardo C, Li GC, et al: Allotype imbalance or microsatellite mutation in low-grade soft tissue sarcomas of the extremities in adults. J Pathol 198:21-29, 2002
14. Eriksson A, Lewensoh R, Larsson R, et al: DNA-dependent protein kinase in leukemia cells and correlation with drug sensitivity. Anticancer Res 22:1787-1793, 2002
15. Kuschel B, Auranen A, McBride S, et al: Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 11:1399-1407, 2002
16. Chai W, Ford LP, Lenertz L, et al: Human Ku70/80 physically associates with telomerase through interaction with hTERT. J Biol Chem 277:47242-47247, 2002
17. Liu X, Lin J, Huang J, et al: Upregulation of ku expression in human neuroectodermal tumor cells after retroviral DNA integration. Intervirology 45:183-187, 2002
18. Choi EK, Lee YH, Choi YS, et al: Heterogenous expression of Ku70 in human tissues is associated with morphological and functional alterations of the nucleus. J Pathol 198:121-130, 2002
19. Gancberg D, DiLeo A, Rouas G, et al: Reliability of the tissue microarray based FISH for evaluation of the HER-2 oncogene in breast carcinoma. J Clin Pathol 55:315-317, 2002
20. Mousses S, Bubendorf L, Wagner U, et al: Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res 62:1256-1260, 2002
21. Saito A, Fujii G, Sato Y, et al: Detection of genes expressed in primary colon cancers by in situ hybridization: Overexpression of RACK1. Mol Pathol 55:34-39, 2002
22. Skacel M, Skilton B, Pettay JD, et al: Tissue microarrays: A powerful tool for high-throughput analysis of clinical specimens. A review of the method with validation data. Appl Immunohistochem Mol Morphol 10:1-6, 2002
23. Urdea MS: Synthesis and characterization of branched DNA (bDNA) for the direct and quantitative detection of CMV, HBV, HCV, and HIV. Clin Chem 39:725-726, 1993
24. Fox J, Hsu L, Legator PH: Fluorescence in situ hybridization: Powerful molecular tool for cancer research. Clin Chem 41:1554-1559, 1995
25. Kadkol SS, Gage WR, Pasternack GR: In situ hybridization theory and practice. Mol Diagn 4:169-183, 1999
26. Nakamine SM, Tamura H, Takenaka T: Detection of Epstein-Barr virus transcripts in anaplastic large cell lymphomas by mRNA in situ hybridization. Hum Pathol 28:14151-1419, 1997